Flagship Spotlight: Michael Argyres, MD

Michael Argyres, MD, is Flagship’s Director of Pathology, diagnostic biomarkers. Mike received his BA at UC Berkeley in molecular biology, his MD at the Medical College of Wisconsin, did his pathology residency at the University of Colorado, a surgical pathology fellowship at Stanford University, and completed an Advanced Practical Program in Prostate Pathology offered by the College of American Pathologists.

Here’s more from Mike.

“I was always interested in biology and was dissecting frogs before I started kindergarten. I enjoyed molecular biology research but wanted to have a more direct impact on people’s lives, so I went to medical school.

Dr. Michael Argyres

Before joining Flagship, I was a hospital-based anatomic and clinical pathologist for 20 years in community and academic practice. Prior to that, I did molecular biology research on rous sarcoma virus at UC Berkeley, and Apolipoprotein B research at the Gladstone Foundation in San Francisco.

At Flagship, I am passionate about furthering the tools that pathologists use to determine prognosis and prediction of response to therapy for cancer patients. I am also thrilled to be actively working on clinical trials in gene therapy, a dream of mine since learning about the Philadelphia chromosome my first year in college (1985!)

Looking toward the future, I believe that computational pathology will revolutionize the field of pathology by bringing quantitative analytics to a field long relegated to subjective, verbal interpretations.

My advice for aspiring scientists, doctors, and researchers is that there are endless possibilities. Dream big, become part of a great team like the one at Flagship, and enjoy your time here on earth. You only get one life to live, so make it worthwhile.”

Sign up to receive industry and company news, including The Cut Point, Flagship’s quarterly e-newsletter.

Recent Posts

Flagship Biosciences Is Honored with a Best Practices Award

We are honored to announce that Flagship Biosciences has earned a Frost & Sullivan 2023 North American Customer Value Leadership Award in the AI-enabled digital pathology solutions market. Following from detailed evaluation of best practices criteria, the award...

Flagship Biosciences hires Tom Turi, Ph.D. as CSO

Accomplished industry executive strengthens company’s position as a leader in spatial biology and biomarker analytics.BROOMFIELD, CO - September 27, 2022 — Flagship Biosciences, Inc., a leader in spatial biology and biomarker analytics services, announced the hiring...